Highest Score

Ranked by analysis score
Ranks this page's recent reports by score.
Interparfums, Inc.
IPAR·Consumer Staples
A ★★★★Buy
Current$113.46
Target$128.53
Return+13.3%
Aug 20, 2026

Interparfums is an elite, asset-light compounder dominating the prestige fragrance market with an impenetrable portfolio of exclusive luxury licenses, though investors must remain vigilant regarding the persistent threat of supply chain tariffs and geographic demand shocks.

Score
86
Bread Financial Holdings, Inc.
BFH·Financials
A ★★★★Buy
Current$111.10
Target$130.00
Return+17.0%
Aug 20, 2026

Bread Financial is successfully executing a massive fundamental turnaround by stabilizing credit losses and aggressively retiring undervalued shares, though investors must continuously monitor the vulnerability of the U.S. consumer to any sudden macroeconomic shock.

Score
86
Hagerty, Inc.
HGTY·Financials
A ★★★★Buy
Current$12.81
Target$14.88
Return+16.2%
Aug 19, 2026

Hagerty is a monopolistic, highly profitable tollbooth on the multi-billion-dollar collector car ecosystem with compounding structural growth, though investors must vigilantly monitor underwriting volatility as the firm transitions to retaining 100% of its insurance risk.

Score
86
DLocal Limited
DLO·Technology
A ★★★★Buy
Current$13.91
Target$16.95
Return+21.9%
Aug 19, 2026

dLocal is an immensely profitable, fast-growing tollbooth monopolizing enterprise payment routing into emerging markets, trading at a deeply depressed free cash flow multiple, though investors must tolerate persistent take-rate compression and the intense psychological drag of large-scale founder divestitures.

Score
86
LivaNova PLC
LIVN·Healthcare
A ★★★★Buy
Current$81.48
Target$91.35
Return+12.1%
Aug 18, 2026

LivaNova is a deeply entrenched medical device compounder perfectly positioned to harvest explosive margin expansion from recent Medicare reimbursement hikes, though investors must tolerate near-term execution risk surrounding its critical supply chain scale-up and sleep apnea regulatory filings.

Score
86
Excelerate Energy, Inc.
EE·Energy
A ★★★★Buy
Current$36.63
Target$43.66
Return+19.2%
Aug 18, 2026

Excelerate has masterfully transformed into an integrated, cash-printing global LNG utility trading at a deeply misunderstood growth multiple, though investors must stomach the inherent geopolitical volatility of its emerging-market sovereign counterparties.

Score
86
Nelnet, Inc.
NNI·Financials
A ★★★★Buy
Current$127.79
Target$140.00
Return+9.6%
Aug 18, 2026

Nelnet is an exceptional capital-compounding machine disguised as a boring student loan servicer, using massive cash flows from an amortizing legacy portfolio to fund highly profitable tech and banking ventures at a deep discount to its true sum-of-the-parts intrinsic value.

Score
86
WillScot Holdings Corporation
WSC·Industrials
A ★★★★Buy
Current$23.76
Target$29.40
Return+23.7%
Aug 18, 2026

WillScot is an impenetrable, cash-printing infrastructure monopoly trading at a deeply misunderstood discount due to optical margin compression from massive new project wins, though investors must monitor its elevated debt leverage against the backdrop of fluctuating non-residential construction cycles.

Score
86
Laureate Education, Inc.
LAUR·Consumer Discretionary
A ★★★★Buy
Current$37.62
Target$41.31
Return+9.8%
Aug 17, 2026

Laureate Education is a highly efficient, cash-gushing tollbooth for Latin American economic mobility, aggressively compounding per-share value through relentless buybacks, provided investors can stomach the inherent volatility of the Mexican Peso and Peruvian Sol.

Score
86
Sphere Entertainment Co.
SPHR·Communication Services
A ★★★★Buy
Current$168.00
Target$215.33
Return+28.2%
Aug 17, 2026

Sphere Entertainment is the undisputed, highly scalable monopoly of ultra-immersive live entertainment, poised for massive margin expansion via a capital-light global franchise model, though investors must tolerate the structural drag of its legacy regional sports networks.

Score
86
Cousins Properties Incorporated
CUZ·Real Estate
A ★★★★Buy
Current$29.70
Target$34.04
Return+14.6%
Aug 17, 2026

Cousins is the undisputed, elite landlord of the Sun Belt's corporate migration boom, trading at a heavily discounted valuation due to irrational sector-wide panic, though investors must vigilantly monitor the long-term structural threats posed by hybrid work and tech-sector concentration.

Score
86
Brunswick Corporation
BC·Consumer Discretionary
A ★★★★Buy
Current$82.67
Target$91.00
Return+10.1%
Aug 17, 2026

Brunswick is the undisputed, vertically integrated tollbooth of the global marine industry, generating immense free cash flow through its engine monopoly and recurring aftermarket sales, though investors must navigate near-term volatility tied to elevated consumer financing costs and shifting trade tariffs.

Score
86
Balchem Corporation
BCPC·Materials
A ★★★★Buy
Current$178.51
Target$209.00
Return+17.1%
Aug 17, 2026

Balchem is a highly profitable specialty ingredients compounder with an impenetrable moat in proprietary encapsulation technology, justifying its premium valuation through relentless execution and structural growth in global nutrition.

Score
86
Ryan Specialty Holdings, Inc.
RYAN·Financials
A ★★★★Buy
Current$41.82
Target$50.34
Return+20.4%
Aug 16, 2026

Ryan Specialty is the indispensable, elite tollbooth of the complex E&S insurance market, currently trading at a highly attractive valuation due to temporary restructuring friction, though investors must remain hyper-vigilant regarding the cyclical softening of commercial property rates and the encroaching capacity of admitted carriers.

Score
86
ESAB Corporation
ESAB·Industrials
A ★★★★Buy
Current$85.58
Target$108.93
Return+27.3%
Aug 16, 2026

ESAB is executing a masterful, high-margin transformation into an industrial software and inspection powerhouse, trading at a deeply misunderstood discount, though investors must tolerate near-term balance sheet leverage as the company digests its massive acquisition.

Score
86
Ascendis Pharma A/S
ASND·Healthcare
A ★★★★Buy
Current$255.46
Target$310.00
Return+21.4%
Aug 16, 2026

Ascendis Pharma's TransCon technology platform is rapidly scaling a highly profitable rare disease portfolio led by Yorvipath and Yuviwel, though investors must monitor ongoing BioMarin patent litigation and reliance on a single drug delivery mechanism.

Score
86
Credicorp Ltd.
BAP·Financials
A ★★★★Buy
Current$386.36
Target$440.00
Return+13.9%
Aug 16, 2026

Credicorp is the highly profitable, monopolistic tollbooth of Peruvian finance, successfully scaling its Yape fintech ecosystem to lock in decades of structural growth, though investors must remain hyper-vigilant regarding provisioning spikes tied to unpreventable macro and climate shocks.

Score
86
Amdocs Limited
DOX·Technology
A ★★★★Buy
Current$58.66
Target$81.62
Return+39.1%
Aug 16, 2026

Amdocs is an impenetrable, highly cash-generative tollbooth for global telecom operations trading at a deeply distressed valuation, though investors must accept stagnant top-line growth tied to constrained carrier capital expenditures.

Score
86
Wyndham Hotels & Resorts, Inc.
WH·Consumer Discretionary
A ★★★★Buy
Current$74.31
Target$90.09
Return+21.2%
Aug 16, 2026

Wyndham is the undisputed, asset-light tollbooth of the global economy and midscale lodging market, trading at a steep discount to its cash-generation power, though investors must monitor the ongoing macroeconomic strain on its core blue-collar consumer base.

Score
86
Enact Holdings, Inc.
ACT·Financials
A ★★★★Buy
Current$49.78
Target$55.00
Return+10.5%
Aug 14, 2026

Enact Holdings operates as a highly disciplined, cash-generating fortress within the U.S. mortgage insurance oligopoly, relentlessly compounding per-share value through aggressive buybacks and flawless credit risk transfer, though investors face the overhang of Genworth's majority ownership.

Score
86
Super Micro Computer, Inc.
SMCI·Technology
A ★★★★Buy
Current$39.15
Target$63.00
Return+60.9%
Aug 14, 2026

Super Micro holds a monopolistic grip on the liquid-cooled AI infrastructure market, trading at a deeply discounted 12x forward multiple against a verified $60B backlog, though extreme working capital demands and margin volatility require high investor risk tolerance.

Score
86
Madison Square Garden Sports Corp.
MSGS·Communication Services
A ★★★★Buy
Current$412.98
Target$522.28
Return+26.5%
Aug 14, 2026

MSG Sports offers investors a deeply discounted backdoor into owning two iconic, irreplaceable New York sports monopolies just as management executes a definitive spin-off catalyst designed to aggressively unlock billions in trapped shareholder value.

Score
86
Smithfield Foods, Inc.
SFD·Consumer Staples
A ★★★★Buy
Current$22.47
Target$31.00
Return+38.0%
Aug 14, 2026

Smithfield Foods offers an impregnable balance sheet, a highly accretive 5.56% dividend, and immense branded pricing power trading at a severe geopolitical discount, though investors must stomach structural governance risks tied to its overwhelming Chinese parent ownership.

Score
86
Gates Industrial Corporation plc
GTES·Industrials
A ★★★★Buy
Current$27.86
Target$33.45
Return+20.1%
Aug 13, 2026

Gates Industrial is a highly profitable, cash-gushing compounder leveraging its dominant aftermarket position to shield against industrial cyclicality, while an emerging structural growth catalyst in data center liquid cooling provides powerful, unexpected upside to its fundamentally cheap valuation.

Score
86